Biohaven Pharmaceutical Holding Company Ltd. logo

Biohaven Pharmaceutical Holding Company Ltd.

NYSE:BHVN

Overview | Financials
Company Name Biohaven Pharmaceutical Holding Company Ltd.
Symbol BHVN
Currency USD
Price 36.9
Market Cap 3,488,609,025
Dividend Yield 0%
52-week-range 16.45 - 62.21
Industry Biotechnology
Sector Healthcare
CEO Dr. Vladimir Coric M.D.
Website https://www.biohavenpharma.com

An error occurred while fetching data.

About Biohaven Pharmaceutical Holding Company Ltd.

Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavegepant that is in phase III

Related Stocks

Financials

Numbers are in millions USD

Numbers are in millions USD